| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Chemistry and Coalition for Biomolecular Products, The University of Alabama Tuscaloosa, Alabama
Address reprint requests to: John B. Vincent, Department of Chemistry and Coalition for Biomolecular Products, The University of Alabama, Tuscaloosa, AL 35487-0336
Chromium has long been known to be essential for proper lipid and carbohydrate metabolism in mammals, with chromium deficiency leading to symptoms associated with adult-onset diabetes and cardiovascular disease. Elucidating the structure, function, and mode of action of the biologically active form of chromium has proved enigmatic. However, a naturally-occurring oligopeptide, low-molecular-weight chromium-binding substance (LMWCr), has been found in our laboratory to activate insulin receptor kinase activity up to 7-fold with a dissociation constant of 250 picomolar in the presence of 100 nanomolar insulin, and it has been partially characterized in terms of structural and spectroscopic properties. LMWCr may function in a manner similar to that of the calcium-binding signal protein calmodulin. In other words, LMWCr is maintained in its active apo-oligopeptide form; in response to a chromium flux, LMWCr binds 4 chromic ions. The holoprotein is then capable of binding to insulin receptor (and perhaps other enzymes) activating the enzyme. Establishing a link between the nutrient chromium, LMWCr’s activation of insulin receptor kinase activity, and adult-onset diabetes and related conditions could result in a new treatment for these conditions.
Key words: chromium, low-molecular-weight chromium-binding substance, insulin receptor, kinase
This article has been cited by other articles:
|
|
 |
|
  M. Via, C. Scurlock, J. Raikhelkar, G. D. Luozzo, and J. I. Mechanick Chromium Infusion Reverses Extreme Insulin Resistance in a Cardiothoracic ICU Patient Nutr Clin Pract, June 1, 2008; 23(3): 325 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Chen, P. Liu, G. R. Pattar, L. Tackett, P. Bhonagiri, A. B. Strawbridge, and J. S. Elmendorf Chromium Activates Glucose Transporter 4 Trafficking and Enhances Insulin-Stimulated Glucose Transport in 3T3-L1 Adipocytes via a Cholesterol-Dependent Mechanism Mol. Endocrinol., April 1, 2006; 20(4): 857 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Q. Wang, X. H. Zhang, J. C. Russell, M. Hulver, and W. T. Cefalu Chromium Picolinate Enhances Skeletal Muscle Cellular Insulin Signaling In Vivo in Obese, Insulin-Resistant JCR:LA-cp Rats J. Nutr., February 1, 2006; 136(2): 415 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Guallar, F. J. Jimenez, P. van 't Veer, P. Bode, R. A. Riemersma, J. Gomez-Aracena, J. D. Kark, L. Arab, F. J. Kok, J. M. Martin-Moreno, et al. Low Toenail Chromium Concentration and Increased Risk of Nonfatal Myocardial Infarction Am. J. Epidemiol., July 15, 2005; 162(2): 157 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. T. Cefalu and F. B. Hu Role of Chromium in Human Health and in Diabetes Diabetes Care, November 1, 2004; 27(11): 2741 - 2751. [Full Text] [PDF]
|
|
|
|
 |
|
 G. J Ryan, N. S Wanko, A. R Redman, and C. B Cook Chromium as Adjunctive Treatment for Type 2 Diabetes Ann. Pharmacother., June 1, 2003; 37(6): 876 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C Lukaski Magnesium, zinc, and chromium nutriture and physical activity Am. J. Clinical Nutrition, August 1, 2000; 72(2): 585S - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Vincent The Biochemistry of Chromium J. Nutr., April 1, 2000; 130(4): 715 - 718. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
